help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0939
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/12/6699    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacob, K. N.
Right arrow Articles by Garg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacob, K. N.
Right arrow Articles by Garg, A.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*Genetics Home Reference

Submitted on April 29, 2005
Accepted on September 8, 2005

Phenotypic Heterogeneity in Body Fat Distribution in Patients with Atypical Werner's Syndrome due to Heterozygous Arg133Leu Lamin A/C Mutation

Katherine N. Jacob, Fernando Baptista, Heloísa G. dos Santos, Junko Oshima, Anil K. Agarwal, and Abhimanyu Garg*

Division of Nutrition and Metabolic Diseases, Department of Internal Medicine and the Center for Human Nutrition (K.N.J., A.K.A., A.G.), University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390; Medical Genetics Service (H.G.S.) and Endocrinology Unit (F.B.), Santa Maria Hospital, Lisbon, Portugal; and Department of Pathology (J.O.), University of Washington, Seattle, Washington 98195

* To whom correspondence should be addressed. E-mail: Abhimanyu.garg{at}utsouthwestern.edu.

Context. A heterozygous missense mutation substituting arginine at position 133 to leucine in the lamin A/C protein has been reported in two young women with clinical features of short stature, bird-like facies and early onset of aging processes.

Objective. To carry out detailed phenotyping of these two women by evaluating the pattern of fat loss using anthropometry, dual energy x-ray absorptiometry (DEXA), and magnetic resonance imaging (MRI) and to study metabolic abnormalities in glucose and lipid metabolism.

Design. Descriptive Case Reports.

Setting. Referral Center.

Patients. Patient 1 was a 23-year-old African-American female with progeroid features. Patient 2 was a 24-year-old Caucasian female with generalized lipodystrophy, hypertriglyceridemia and severe insulin resistance diabetes who required over 200 U of insulin daily.

Interventions. None

Main Outcome Measures. Body fat distribution to characterize pattern of lipodystrophy and to study nuclear morphology abnormalities in skin fibroblasts.

Results. Patient 1 had normal body fat (27%) by DEXA. However, MRI revealed relative paucity of sc fat in the distal extremities, with preservation of sc truncal fat. She had impaired glucose tolerance and elevated post-prandial serum insulin levels. Patient 2 in contrast, had only 11.6% body fat as determined by DEXA and had generalized loss of sc and intra-abdominal fat on MRI. Skin fibroblasts from patient 2 showed marked abnormal nuclear morphology compared with those from patient 1. Despite the deranged nuclear morphology, the lamin A/C remained localized to the nuclear envelope and the nuclear DNA remained within the nucleus.

Conclusions. Atypical Werner's syndrome associated with Arg133Leu mutation in LMNA gene presents with a phenotypically heterogeneous disorder. Furthermore, the severity of metabolic complications seems to correlate with the extent of lipodystrophy.


Key words: Progeria • Lamin A/C • Lipodystrophy




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. Kandert, Y. Luke, T. Kleinhenz, S. Neumann, W. Lu, V. M. Jaeger, M. Munck, M. Wehnert, C. R. Muller, Z. Zhou, et al.
Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells
Hum. Mol. Genet., December 1, 2007; 16(23): 2944 - 2959.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Decaudain, M.-C. Vantyghem, B. Guerci, A.-C. Hecart, M. Auclair, Y. Reznik, H. Narbonne, P.-H. Ducluzeau, B. Donadille, C. Lebbe, et al.
New Metabolic Phenotypes in Laminopathies: LMNA Mutations in Patients with Severe Metabolic Syndrome
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4835 - 4844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society